MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The effects of deep brain stimulation for Parkinson’s disease on cognition and perceived quality of life: Preliminary results from an Ecuadorian sample

    M.B. Jurado Noboa, R. Santibañez Vásquez, J. Achi, M. Navarrete, C. Mawyin (Guayaquil, Ecuador)

    Objective: To evaluate the effects of deep brain stimulation (DBS) on cognition and perceived quality of life in the first cohort of patients undergoing DBS…
  • 2016 International Congress

    Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination

    R. Breder, M.A.A. Leite, M.C.A. Ribas, M. Orsini (Niterói, Brazil)

    Objective: To evaluate the correlation between cognitive and functional performance of Parkinsonian with normal Mini-Mental State Examination (MMSE), and demographic variables, motor impairment, neuropsychiatric disorders…
  • 2016 International Congress

    Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size

    I. Obeso, E. Casabona, R. Rodríguez-Rojas, N. Pavón, R. Macías, M.L. Bringas, J.A. Obeso, M. Jahanshahi (Madrid, Spain)

    Objective: To assess cognitive and neuropsychiatric effects of unilateral subthalamotomy in Parkinson´s disease (PD) and their correlation with lesion size. Background: Surgery for treatment of…
  • 2016 International Congress

    The effect of statin use on cognition in Parkinson’s disease

    B.L. Deck, J. Rick, S.X. Xie, A. Chen-Plotkin, J.E. Duda, J.F. Morley, L.M. Chahine, N. Dahodwala, R.S. Akhtar, J.Q. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To evaluate the effect of statin (HMG CoA reductase inhibitor) use on 1) baseline cognition; 2) rate of cognitive decline; and 3) conversion from…
  • 2016 International Congress

    Apraxia in Parkinson’s disease

    M. Tábuas-Pereira, P. Correia, F. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)

    Objective: We aim to study apraxia in Parkinson's disease. Background: Limb apraxia is a cognitive motor disorder of skilled, purposive movements not caused by elementary…
  • 2016 International Congress

    Reward insensitivity differentiates apathy from depression in Parkinson’s disease

    K. Muhammed, M. Ben Yehuda, D. Drew, S. Manohar, T. Chong, G. Tofaris, M. Bogdanovic, G. Lennox, M. Hu, M. Husain (Oxford, United Kingdom)

    Objective: To determine if a potential cause of apathy in Parkinson's disease (PD) might be insensitivity to rewards, establish if this differentiates apathy from depression…
  • 2016 International Congress

    Psychiatric manifestations in the initial motor stage of Parkinson’s disease

    I. Stankovic, E. Stefanova, A. Tomic, M. Jecmenica Lukic, V. Markovic, N. Kresojevic, I. Petrovic, M. Svetel, V.S. Kostic (Belgrade, Serbia)

    Objective: To estimate the prevalence and correlates of neuropsychiatric symptoms (NPS) in a cohort of consecutive patients with Parkinson's disease (PD) recruited in the initial…
  • 2016 International Congress

    Assessment of cognitive-motor interference during an upper extremity motor task in Parkinson’s disease

    P.J.M. Bank, J. Marinus, J.H. de Groot, J.J. van Hilten, C.G.M. Meskers (Leiden, Netherlands)

    Objective: To assess cognitive-motor interference (CMI) and task prioritization during simultaneous performance of a cognitive task and an upper extremity motor task in Parkinson's disease…
  • 2016 International Congress

    Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson’s disease

    V. Dibilio, A. Nicoletti, G. Mostile, S. Toscano, A. Luca, L. Raciti, R. Vasta, C.E. Cicero, D. Contrafatto, M. Zappia (Catania, Italy)

    Objective: To evaluate an instrumented version of Timed Up and Go Test (iTUG) in patients with Parkinson's disease (PD), both in L-dopa OFF and ON-state.…
  • 2016 International Congress

    Pisa syndrome in a drug-naive Parkinson’s disease patient

    P. Solla, A. Cannas, M.M. Mascia, M. Mancino, D. Picciau, R. Farris, G. Orofino, L. Cugusi, L. Polizzi, F. Marrosu (Monserrato (Cagliari), Italy)

    Objective: We report on a patient who presented a reversible Pisa syndrome without any dopaminergic treatment at onset and before diagnosis of Parkinson's disease (PD).…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley